Praxis Precision Medicines to Present at Upcoming Investor Conferences

Rhea-AI Summary

Praxis Precision Medicines (NASDAQ: PRAX) has announced its participation in two upcoming investor conferences. The first is the Citi Biotech Virtual Co-Panel Day on May 18, 2022, featuring panels on 'Mood Disorders/Mental Health' at 11:00 a.m. ET and 'Movement Disorders/Epilepsy' at 3:30 p.m. ET. The second is the H.C. Wainwright Global Investment Conference, where a company presentation will be available on May 24, 2022, at 7:00 a.m. ET. Webcasts of these events can be accessed on their website, with replays available for 90 days.

BOSTON, May 11, 2022 (GLOBE NEWSWIRE) -- Praxis Precision Medicines, Inc. (NASDAQ: PRAX), a clinical-stage biopharmaceutical company translating genetic insights into the development of therapies for central nervous system (CNS) disorders characterized by neuronal excitation-inhibition imbalance, today announced that management will participate in the following upcoming investor conferences:

• Citi Biotech Virtual Co-Panel Day
        º  ‘Mood Disorders/Mental Health’ panel on Wednesday, May 18, 2022 at 11:00 a.m. ET
        º  ‘Movement Disorders/Epilepsy’ panel on Wednesday, May 18, 2022 at 3:30 p.m. ET
  
  
• H.C. Wainwright Global Investment Conference
        º  Company presentation available on Tuesday, May 24, 2022 at 7:00 a.m. ET

The events will be available via webcast through the Events & Presentations page of the Investors + Media section of the company’s website at www.praxismedicines.com. Replays of the webcasts will be available for 90 days following the event.

About Praxis
Praxis Precision Medicines is a clinical-stage biopharmaceutical company translating genetic insights into the development of therapies for CNS disorders characterized by neuronal excitation-inhibition imbalance. Praxis is applying insights from genetic epilepsies to both rare and more prevalent neurological and psychiatric disorders, using our understanding of shared biological targets and circuits in the brain. Praxis has established a broad portfolio with multiple programs, including product candidates across psychiatric disorders, movement disorders and epilepsy, with three clinical-stage product candidates. For more information, please visit www.praxismedicines.com and follow us on LinkedIn and Twitter.

FAQ

What is the date for the Citi Biotech Virtual Co-Panel Day involving PRAX?

The Citi Biotech Virtual Co-Panel Day is scheduled for May 18, 2022.

At what time will the Mood Disorders/Mental Health panel start on May 18, 2022?

The Mood Disorders/Mental Health panel will start at 11:00 a.m. ET.

When will the H.C. Wainwright Global Investment Conference presentation for PRAX be available?

The H.C. Wainwright Global Investment Conference presentation will be available on May 24, 2022, at 7:00 a.m. ET.

How long will the webcasts from the conferences featuring PRAX be available?

The webcasts will be available for 90 days following the events.

Where can I access the webcasts for the upcoming PRAX investor conferences?

The webcasts can be accessed through the Events & Presentations page on Praxis's website.